LEAD 202512 February 2026 LEAD Perspective: The Taiwan Liver Story – Hepatitis Elimination and HCC SurveillanceREAD MORE
LEAD 202512 February 2026 LEAD Perspective: Asia Pacific Consensus Statement on the clinical and economic utility of biomarker-based algorithms in the early detection and surveillance of HCCREAD MORE
LEAD 202512 February 2026 LEAD Perspective: Taiwan’s Liver Disease Patients – From Chronic Hepatitis to Cancer CareREAD MORE
Disease Awareness4 December 2024 End-to-end liver disease management at Zhuhai People’s Hospital: Project PearlRead More
Health Economics27 June 2024 Cost-Utility of Novel Biomarker-Based Strategies for Hepatocellular Carcinoma (HCC) Surveillance in ThailandRead More
